Consent to the Distribution of Changed Medicines Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution inNew Zealand of the changed medicines which were referred to the Minister of Health under the provisions of section 24 (5) of the Act, and are set out in the Schedule hereto: Schedule Name and Strength Form Name and Address of Manufacturer Proprietary Name(if any) Phenylephrine hydrochloride 1.2 mg/mL in 0.4 mL Eye drops Allergan Optical, Allergan Inc., Waco, Texas, United States of America and Allergan Pharmaceuticals (Ireland) Limited, Westport, County Mayo, Ireland Albalon Relief Lithium succinate 8% w/w, zinc sulphate 0.05% w/w Cream, skin J Pickles & Sons, Knaresborough, Yorkshire, England Efalith Erythropoietin, human recombinant 1,000 IU in 0.5 mL, 2,000 IU, 4,000 IU, 10,000 IU in 1 mL Injection, vial Cilag, AG., Schaffhausen, Switzerland, and Janssen Pharmaceutica nv., Beerse, Belgium Eprex (phosphate buffered) Mesna 400 mg, 600 mg Tablets Asta Medica AG., Halle-Kunsebeck, Germany Uromitexan Dated this 5th day of August 1996. CLARE VAN DER LEM, Acting Assistant General Manager, Health Regulation & Protection, pursuant to delegation given by the Minister of Health on the 18th day of January 1996.